Travere Therapeutics, Inc.
TVTXBiotechnology
$50.57−0.54%As of Oct 29vs prior close
- Market cap
- $4.7B
- P/E (TTM)
- –
- From 52W high
- −25.10%
- EPS (LTM)
- -$0.45
- Revenue (LTM)
- $591.3M
- Net margin
- -7.35%
- Dividend yield
- 0.00%
Nomior Score
77
Ascendant MoverSpeculativeTop 4% of the scored universe
Growth86
Quality65
Value—
Momentum81
Resilience49
Growth
+15.55%revenue a year over 9 fiscal years
YE16 $133.6MLTM $591.3M
Connections
Revenue to profitQ2 YE26
The net loss was 21% of revenue, wider by 9 pts on a year.
Who owns it
2funds, 1 tracked portfolio